39 related articles for article (PubMed ID: 16024624)
1. Integrated analysis of pivotal biomarker of LSM1, immune cell infiltration and therapeutic drugs in breast cancer.
Tzeng YT; Tsui KH; Tseng LM; Hou MF; Chu PY; Sheu JJ; Li CJ
J Cell Mol Med; 2022 Jul; 26(14):4007-4020. PubMed ID: 35692083
[TBL] [Abstract][Full Text] [Related]
2. Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma.
Zhuang H; Chen B; Tang C; Chen X; Tan W; Yang L; Xie Z; Ma X; Wang Q; Zhang C; Shang C; Chen Y
Front Oncol; 2022; 12():871771. PubMed ID: 35646684
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value and potential molecular mechanism of the like-Sm gene family in early-stage pancreatic ductal adenocarcinoma.
Chen Z; Han C; Zhou X; Wang X; Liao X; He Y; Mo S; Li X; Zhu G; Ye X; Peng T
Transl Cancer Res; 2021 Apr; 10(4):1744-1760. PubMed ID: 35116499
[TBL] [Abstract][Full Text] [Related]
4. The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells.
Little EC; Camp ER; Wang C; Watson PM; Watson DK; Cole DJ
Oncogenesis; 2016 Jan; 5(1):e182. PubMed ID: 26751936
[TBL] [Abstract][Full Text] [Related]
5. Induction of olfaction and cancer-related genes in mice fed a high-fat diet as assessed through the mode-of-action by network identification analysis.
Choi Y; Hur CG; Park T
PLoS One; 2013; 8(3):e56610. PubMed ID: 23555558
[TBL] [Abstract][Full Text] [Related]
6. Detection of IGF2BP3, HOXB7, and NEK2 mRNA expression in brush cytology specimens as a new diagnostic tool in patients with biliary strictures.
Nischalke HD; Schmitz V; Luda C; Aldenhoff K; Berger C; Feldmann G; Sauerbruch T; Spengler U; Nattermann J
PLoS One; 2012; 7(8):e42141. PubMed ID: 22879911
[TBL] [Abstract][Full Text] [Related]
7. Lsm1 promotes genomic stability by controlling histone mRNA decay.
Herrero AB; Moreno S
EMBO J; 2011 May; 30(10):2008-18. PubMed ID: 21487390
[TBL] [Abstract][Full Text] [Related]
8. LSm1-7 complexes bind to specific sites in viral RNA genomes and regulate their translation and replication.
Galão RP; Chari A; Alves-Rodrigues I; Lobão D; Mas A; Kambach C; Fischer U; Díez J
RNA; 2010 Apr; 16(4):817-27. PubMed ID: 20181739
[TBL] [Abstract][Full Text] [Related]
9. Activation of decapping involves binding of the mRNA and facilitation of the post-binding steps by the Lsm1-7-Pat1 complex.
Chowdhury A; Tharun S
RNA; 2009 Oct; 15(10):1837-48. PubMed ID: 19643916
[TBL] [Abstract][Full Text] [Related]
10. LSM1 over-expression in Saccharomyces cerevisiae depletes U6 snRNA levels.
Luhtala N; Parker R
Nucleic Acids Res; 2009 Sep; 37(16):5529-36. PubMed ID: 19596813
[TBL] [Abstract][Full Text] [Related]
11. CaSm (LSm-1) overexpression in lung cancer and mesothelioma is required for transformed phenotypes.
Watson PM; Miller SW; Fraig M; Cole DJ; Watson DK; Boylan AM
Am J Respir Cell Mol Biol; 2008 Jun; 38(6):671-8. PubMed ID: 18218995
[TBL] [Abstract][Full Text] [Related]
12. Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer.
Lyng H; Brøvig RS; Svendsrud DH; Holm R; Kaalhus O; Knutstad K; Oksefjell H; Sundfør K; Kristensen GB; Stokke T
BMC Genomics; 2006 Oct; 7():268. PubMed ID: 17054779
[TBL] [Abstract][Full Text] [Related]
13. Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon.
Streicher KL; Yang ZQ; Draghici S; Ethier SP
Oncogene; 2007 Mar; 26(14):2104-14. PubMed ID: 17001308
[TBL] [Abstract][Full Text] [Related]
14. CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability.
Fraser MM; Watson PM; Fraig MM; Kelley JR; Nelson PS; Boylan AM; Cole DJ; Watson DK
Cancer Res; 2005 Jul; 65(14):6228-36. PubMed ID: 16024624
[TBL] [Abstract][Full Text] [Related]
15. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
16. CaSm: an Sm-like protein that contributes to the transformed state in cancer cells.
Schweinfest CW; Graber MW; Chapman JM; Papas TS; Baron PL; Watson DK
Cancer Res; 1997 Jul; 57(14):2961-5. PubMed ID: 9230209
[TBL] [Abstract][Full Text] [Related]
17. CaSm antisense gene therapy: a novel approach for the treatment of pancreatic cancer.
Kelley JR; Fraser MM; Hubbard JM; Watson DK; Cole DJ
Anticancer Res; 2003; 23(3A):2007-13. PubMed ID: 12894573
[TBL] [Abstract][Full Text] [Related]
18. The cancer-associated Sm-like oncogene: a novel target for the gene therapy of pancreatic cancer.
Kelley JR; Brown JM; Frasier MM; Baron PL; Schweinfest CW; Vournakis JN; Watson DK; Cole DJ
Surgery; 2000 Aug; 128(2):353-60. PubMed ID: 10923016
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle deregulation: a common motif in cancer.
Malumbres M; Carnero A
Prog Cell Cycle Res; 2003; 5():5-18. PubMed ID: 14593696
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
